Recall of batches of Prazosin Hydrochloride 5 mg produced by Teva Pharmaceuticals USA Manufacturer
2026-02-12
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Prazosin Hydrochloride 5 mg capsules Prazosin Hydrochloride Unregistered 3010403A 3010404A 3010405A 3010510A Teva Pharmaceuticals USA
التصنيف
ملف
التاريخ
2025-11-12
اسم المستحضر
Prazosin Hydrochloride 5 mg capsules
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of batches of Prazosin Hydrochloride 5 mg capsules due to non-compliance with specifications. The SFDA recalled the above batches form local market.
التوصيات
For healthcare professionals: Stop dispensing the affected batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
- Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。